The anti-inflammatory drug tocilizumab targets the IL-6 pathway to achieve a 54% remission rate in hard-to-treat depression.
The Los Angeles County Medical Examiner announced Tuesday that Khimberly had a rare birth condition involving fragile, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results